Source: Annual Congress 2002 - Mesothelioma and malignant pleural effusion
Disease area: Respiratory infections, Thoracic oncology



Rating:

Share or cite this content

Citations should be made in the following way:
D. S. Hyun, T. R. Shin, S. C. Lee, S. H. Jheon, C. H. Jeon (Daegu, South Korea). Diagnostic value of common MAGE RT-PCR in malignant pleural effusion. Eur Respir J 2002; 20: Suppl. 38, 1749

Member's Comments

No comment yet.

Related content which might interest you: Diagnostic value of combined assays in differentiating tuberculous and malignant pleural effusions Source: Annual Congress 2008 - Genetics, immunology and microbiology of tuberculosis Year: 2008 Expression of human mammaglobin gene in pleural effusion of patients affected by malignant pleural mesothelioma (MM) Source: Eur Respir J 2004; 24: Suppl. 48, 81s Year: 2004 Diagnostic value of detection of promoter hypermethylation of tumor suppressor genes in pleural fluid for diagnosis of malignant pleural effusion Source: Annual Congress 2010 - Lung cancer, idiopathic pulmonary fibrosis and sarcoidosis: the genetic approach Year: 2010 Use of carcinoembryonic antigen in pleural effusion for differential diagnosis of benign and malignant pleural effusion Source: Annual Congress 2008 - Diagnostic aspects in thoracic oncology Year: 2008 Diagnostic and prognostic significance of survivin levels in malignant pleural effusion Source: Annual Congress 2011 - Molecular markers: diagnosis and management of malignant pleural effusions Year: 2011 The presence of human mammaglobin transcripts in the pleural effusion is not predictive of survival in patients with malignant mesothelioma Source: Annual Congress 2008 - Biology in thoracic tumours Year: 2008 Detection of mesothelin in the pleural effusion has a higher diagnostic utility than in serum for diagnostic of malignant mesothelioma Source: Annual Congress 2013 –Clinical problems in mediastinal and pleural malignacies Year: 2013 Diagnostic usefulness of tumour markers in pleural effusions Source: Annual Congress 2009 - Diagnosis of pleural effusions and rare tumours experience Year: 2009 Diagnostic utility of pleural CEA and CYFRA 21-1 for malignant pleural effusions Source: Eur Respir J 2003; 22: Suppl. 45, 60s Year: 2003 Diagnostic problems in benign and malignant pleural effusions Source: Annual Congress 2007 - PG16 - Management of pleural problems in your practice today Year: 2007 The diagnostic usefulness of MAGE expression in the diagnosis of exudative pleural effusion Source: Eur Respir J 2004; 24: Suppl. 48, 528s Year: 2004 Utility of pleural fluid for predictive marker testing in malignant pleural effusion Source: Virtual Congress 2020 – Malignant pleural effusion in 2020: understanding the biology and clinical implications Year: 2020 Diagnostic usefulness of C reactive protein levels in pleural effusions of malignant and non malignant origin Source: Eur Respir J 2007; 30: Suppl. 51, 431s Year: 2007 Diagnostic value of pleural effusion for the detection of EGFR in NSCLC: a meta-analysis Source: International Congress 2019 – Diagnosis of lung cancer Year: 2019 Diagnostic value of closed pleural needle biopsy for the diagnosis of malignant and tuberculous pleural effusions Source: Eur Respir J 2005; 26: Suppl. 49, 446s Year: 2005 Diagnostic approach to pleural effusions Source: Annual Congress 2008 - MP7 - Diagnostic approach to pleural effusions Year: 2008 Prognostic significance of pleural tumour burden in patients with malignant pleural effusions Source: Annual Congress 2010 - 100 years of thoracoscopy: still room for improvement? Year: 2010 Diagnostic value of lactatedehydrogenase in pleural effusions Source: Eur Respir J 2002; 20: Suppl. 38, 441s Year: 2002 Diagnostic value of leptin in tuberculous pleural effusions Source: Eur Respir J 2004; 24: Suppl. 48, 426s Year: 2004 Diagnostic value and prognostic significance of pleural C-reactive protein in lung cancer with malignant pleural effusions Source: Annual Congress 2012 - Instructive clinical aspects of thoracic oncology Year: 2012